(Rac)-BRD0705
(Rac)-BRD0705 Basic information
- Product Name:
- (Rac)-BRD0705
- Synonyms:
-
- (Rac)-BRD0705
- GSK3α,inhibit,Racemate,(Rac)BRD0705,GSK-3,Inhibitor,Glycogen synthase kinase-3,(Rac) BRD0705,(Rac)-BRD-0705,Glycogen synthase kinase 3,(Rac)-BRD0705
- 5H-Pyrazolo[3,4-b]quinolin-5-one, 4-ethyl-1,2,4,6,7,8-hexahydro-7,7-dimethyl-4-phenyl-
- (Rac)-BRD0705, 10 mM in DMSO
- 4-ethyl-7,7-dimethyl-4-phenyl-1,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one
- CAS:
- 1597440-03-3
- MF:
- C20H23N3O
- MW:
- 321.42
- Mol File:
- 1597440-03-3.mol
More
Less
(Rac)-BRD0705 Chemical Properties
- Boiling point:
- 512.0±50.0 °C(Predicted)
- Density
- 1.22±0.1 g/cm3(Predicted)
- pka
- 14.82±0.60(Predicted)
- form
- Solid
- color
- Light yellow to yellow
More
Less
(Rac)-BRD0705 Usage And Synthesis
Uses
(Rac)-BRD0705 is a less active racemate of BRD0705. BRD0705 is a potent, paralog selective and orally active GSK3α inhibitor with an IC50 of 66 nM and a Kd of 4.8 μM. BRD0705 displays increased selectivity for GSK3α (8-fold) versus GSK3β (IC50 of 515 nM). BRD0705 can be used for acute myeloid leukemia (AML)[1][2].
References
[1] Wagner FF, et al. Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia. Sci Transl Med. 2018 Mar 7;10(431). pii: eaam8460. DOI:10.1126/scitranslmed.aam8460
[2] Edward Scolnick, et al. Uses of paralog-selective inhibitors of gsk3 kinases. US20160375006A1.
(Rac)-BRD0705Supplier
Shanghai EFE Biological Technology Co., Ltd.
- Tel
- 021-65675885 18964387627
- info@efebio.com
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
TargetMol Chemicals Inc.
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
Wuhan chuang he chemical co. LTD
- Tel
- 15907120073
- 1261789306@qq.com
Hefei fuya biotechnology co. LTD
- Tel
- 18096409024
- sales02@foreversyn.com